We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ahead of Exelon (EXC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Exelon (EXC - Free Report) will report quarterly earnings of $0.70 per share in its upcoming release, pointing to no change from the year-ago quarter. It is anticipated that revenues will amount to $5.72 billion, exhibiting an increase of 2.9% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Exelon metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Operating revenues- PECO [$M]' will likely reach $1.15 billion. The estimate indicates a change of +3.7% from the prior-year quarter.
Based on the collective assessment of analysts, 'Operating revenues- ComEd [$M]' should arrive at $1.78 billion. The estimate indicates a year-over-year change of +6.9%.
Analysts expect 'Operating revenues- BGE [$M]' to come in at $1.21 billion. The estimate points to a change of -3.8% from the year-ago quarter.
Analysts' assessment points toward 'Operating revenues- PHI' reaching $1.59 billion. The estimate points to a change of +3.6% from the year-ago quarter.
The consensus estimate for 'Adjusted Operating Earnings (non-GAAP)- ComEd' stands at $199.46 million. The estimate compares to the year-ago value of $251 million.
According to the collective judgment of analysts, 'Adjusted Operating Earnings (non-GAAP)- PHI' should come in at $195.84 million. The estimate compares to the year-ago value of $173 million.
Analysts predict that the 'Adjusted Operating Earnings (non-GAAP)- BGE' will reach $221.02 million. Compared to the present estimate, the company reported $199 million in the same quarter last year.
Analysts forecast 'Adjusted Operating Earnings (non-GAAP)- PECO' to reach $197.98 million. Compared to the present estimate, the company reported $166 million in the same quarter last year.
Shares of Exelon have experienced a change of -0.7% in the past month compared to the -2% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), EXC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Ahead of Exelon (EXC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Exelon (EXC - Free Report) will report quarterly earnings of $0.70 per share in its upcoming release, pointing to no change from the year-ago quarter. It is anticipated that revenues will amount to $5.72 billion, exhibiting an increase of 2.9% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Exelon metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Operating revenues- PECO [$M]' will likely reach $1.15 billion. The estimate indicates a change of +3.7% from the prior-year quarter.
Based on the collective assessment of analysts, 'Operating revenues- ComEd [$M]' should arrive at $1.78 billion. The estimate indicates a year-over-year change of +6.9%.
Analysts expect 'Operating revenues- BGE [$M]' to come in at $1.21 billion. The estimate points to a change of -3.8% from the year-ago quarter.
Analysts' assessment points toward 'Operating revenues- PHI' reaching $1.59 billion. The estimate points to a change of +3.6% from the year-ago quarter.
The consensus estimate for 'Adjusted Operating Earnings (non-GAAP)- ComEd' stands at $199.46 million. The estimate compares to the year-ago value of $251 million.
According to the collective judgment of analysts, 'Adjusted Operating Earnings (non-GAAP)- PHI' should come in at $195.84 million. The estimate compares to the year-ago value of $173 million.
Analysts predict that the 'Adjusted Operating Earnings (non-GAAP)- BGE' will reach $221.02 million. Compared to the present estimate, the company reported $199 million in the same quarter last year.
Analysts forecast 'Adjusted Operating Earnings (non-GAAP)- PECO' to reach $197.98 million. Compared to the present estimate, the company reported $166 million in the same quarter last year.
View all Key Company Metrics for Exelon here>>>
Shares of Exelon have experienced a change of -0.7% in the past month compared to the -2% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), EXC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>